May 9 |
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
|
May 8 |
Q1 2024 Pulse Biosciences Inc Earnings Call
|
May 8 |
Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
May 7 |
Pulse Biosciences Reports Q1 2024 Financial Results Amidst Strategic Business Developments
|
May 7 |
Pulse Biosciences reports Q1 results
|
May 7 |
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
|
May 2 |
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
|
Apr 24 |
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
|
Apr 4 |
Pulse Biosciences to sell subscription rights to purchase up to 6M units
|
Apr 1 |
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript
|